EUVIMEDObjevte EUVIMED
Editorial

Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply

Yu-Sheng Lin, Hwai-I Yang, Teng-Yu Lee iD

Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1429-1430

DOI: 10.1111/apt.70628 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-03-17. Written by Yu-Sheng Lin and 2 co-authors. Institution: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. 10 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Subjects

Author keywords

genetic risk scorehepatitis Chepatocellular carcinoma

Authors and institutions

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

ORCID profiles: Teng-Yu Lee

Cite

APA

Lin, Y. S., Yang, H. I., & Lee, T. Y. (2026). Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(10), 1429-1430. https://doi.org/10.1111/apt.70628

Vancouver

Lin YS, Yang HI, Lee TY. Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(10):1429-1430. doi:10.1111/apt.70628

BibTeX
@article{Lin2026,
  author = {Lin, Yu-Sheng and Yang, Hwai-I and Lee, Teng-Yu},
  title = {Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {10},
  pages = {1429--1430},
  doi = {10.1111/apt.70628}
}
Start for free →